Shaw Timothy’s RSU Conversion Boosts MariMed Shares—What It Means for Investors
Shaw Timothy’s recent RSU conversion at MariMed shows routine equity activity, not a major shift—focus on upcoming production approvals and sector trends.
3 minutes to read